Sarah Harwood, NP
Gerontology · Spokane Valley, WANPI 1528704889
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $971 of the $1,146 with a category attached, or 84.7%. It is spread thinly across 12 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations.
Across 49 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$268
- Johnson & Johnson$199
- AbbVie$196
- Amgen$124
- Novartis$73
- Regeneron Healthcare Solutions, Inc.$70
- plus $216 from 6 others
What the payments were for
- Food & beverage$97185%
- Education$17515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $268 |
| Johnson & Johnson | 3 | $199 |
| AbbVie | 10 | $196 |
| Amgen | 5 | $124 |
| Novartis | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| UCB, Inc. | 3 | $55 |
| Sanofi | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Revance Therapeutics, Inc. | 1 | $40 |
| Incyte Corporation | 1 | $17 |
| Genentech, Inc. | 1 | $15 |
How this compares
$1,146 in reported general payments places this provider in the 80th percentile of 105 gerontology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $80,456 |
| Clobetasol Propionate | 101 | $4,956 |
| Doxycycline Hyclate | 27 | $3,557 |
| Fluorouracil | 33 | $2,210 |
| Ketoconazole | 93 | $1,242 |
| Triamcinolone Acetonide | 133 | $1,216 |
| Metronidazole | 13 | $776 |
| Betamethasone Dipropionate | 12 | $616 |
| Nystatin | 38 | $549 |
| Clindamycin Phosphate | 11 | $523 |
| ValacyclovirValacyclovir Hcl | 18 | $339 |
| Doxycycline Monohydrate | 14 | $230 |
| Minoxidil | 12 | $191 |
| Mupirocin | 14 | $76 |
| Prednisone | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Spokane Valley
- Byron TatschSpokane Valley$4K
- Amy WoodruffTacoma$118K
- Peter WilcoxSilverdale$16K
- Kristi ParrisSilverdale$10K
- Samuel GodinSilverdale$7K
- Catherine RehbergerTacoma$4K
- Nachole BrownSeattle$4K
- Si FengRichland$3K
- Shanti Benoit BoyceSeattle$3K
- Elizabeth MyrickSeattle$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.